c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis.
<h4>Background</h4>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive death of motor neurons. Although the pathogenesis of ALS remains unclear, several cellular processes are known to be involved, including apoptosis. A previous study re...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/95e88ca923da4d248ec144fba0ba317b |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:95e88ca923da4d248ec144fba0ba317b |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:95e88ca923da4d248ec144fba0ba317b2021-11-18T08:14:02Zc-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis.1932-620310.1371/journal.pone.0046185https://doaj.org/article/95e88ca923da4d248ec144fba0ba317b2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23049975/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive death of motor neurons. Although the pathogenesis of ALS remains unclear, several cellular processes are known to be involved, including apoptosis. A previous study revealed the apoptosis-related gene c-Abl to be upregulated in sporadic ALS motor neurons.<h4>Methodology/findings</h4>We investigated the possibility that c-Abl activation is involved in the progression of ALS and that c-Abl inhibition is potentially a therapeutic strategy for ALS. Using a mouse motor neuron cell line, we found that mutation of Cu/Zn-superoxide dismutase-1 (SOD1), which is one of the causative genes of familial ALS, induced the upregulation of c-Abl and decreased cell viability, and that the c-Abl inhibitor dasatinib inhibited cytotoxicity. Activation of c-Abl with a concomitant increase in activated caspase-3 was observed in the lumbar spine of G93A-SOD1 transgenic mice (G93A mice), a widely used model of ALS. The survival of G93A mice was improved by oral administration of dasatinib, which also decreased c-Abl phosphorylation, inactivated caspase-3, and improved the innervation status of neuromuscular junctions. In addition, c-Abl expression in postmortem spinal cord tissues from sporadic ALS patients was increased by 3-fold compared with non-ALS patients.<h4>Conclusions/significance</h4>The present results suggest that c-Abl is a potential therapeutic target for ALS and that the c-Abl inhibitor dasatinib has neuroprotective properties in vitro and in vivo.Ryu KatsumataShinsuke IshigakiMasahisa KatsunoKaori KawaiJun SoneZhe HuangHiroaki AdachiFumiaki TanakaFumihiko UranoGen SobuePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 9, p e46185 (2012) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Ryu Katsumata Shinsuke Ishigaki Masahisa Katsuno Kaori Kawai Jun Sone Zhe Huang Hiroaki Adachi Fumiaki Tanaka Fumihiko Urano Gen Sobue c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis. |
| description |
<h4>Background</h4>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive death of motor neurons. Although the pathogenesis of ALS remains unclear, several cellular processes are known to be involved, including apoptosis. A previous study revealed the apoptosis-related gene c-Abl to be upregulated in sporadic ALS motor neurons.<h4>Methodology/findings</h4>We investigated the possibility that c-Abl activation is involved in the progression of ALS and that c-Abl inhibition is potentially a therapeutic strategy for ALS. Using a mouse motor neuron cell line, we found that mutation of Cu/Zn-superoxide dismutase-1 (SOD1), which is one of the causative genes of familial ALS, induced the upregulation of c-Abl and decreased cell viability, and that the c-Abl inhibitor dasatinib inhibited cytotoxicity. Activation of c-Abl with a concomitant increase in activated caspase-3 was observed in the lumbar spine of G93A-SOD1 transgenic mice (G93A mice), a widely used model of ALS. The survival of G93A mice was improved by oral administration of dasatinib, which also decreased c-Abl phosphorylation, inactivated caspase-3, and improved the innervation status of neuromuscular junctions. In addition, c-Abl expression in postmortem spinal cord tissues from sporadic ALS patients was increased by 3-fold compared with non-ALS patients.<h4>Conclusions/significance</h4>The present results suggest that c-Abl is a potential therapeutic target for ALS and that the c-Abl inhibitor dasatinib has neuroprotective properties in vitro and in vivo. |
| format |
article |
| author |
Ryu Katsumata Shinsuke Ishigaki Masahisa Katsuno Kaori Kawai Jun Sone Zhe Huang Hiroaki Adachi Fumiaki Tanaka Fumihiko Urano Gen Sobue |
| author_facet |
Ryu Katsumata Shinsuke Ishigaki Masahisa Katsuno Kaori Kawai Jun Sone Zhe Huang Hiroaki Adachi Fumiaki Tanaka Fumihiko Urano Gen Sobue |
| author_sort |
Ryu Katsumata |
| title |
c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis. |
| title_short |
c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis. |
| title_full |
c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis. |
| title_fullStr |
c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis. |
| title_full_unstemmed |
c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis. |
| title_sort |
c-abl inhibition delays motor neuron degeneration in the g93a mouse, an animal model of amyotrophic lateral sclerosis. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2012 |
| url |
https://doaj.org/article/95e88ca923da4d248ec144fba0ba317b |
| work_keys_str_mv |
AT ryukatsumata cablinhibitiondelaysmotorneurondegenerationintheg93amouseananimalmodelofamyotrophiclateralsclerosis AT shinsukeishigaki cablinhibitiondelaysmotorneurondegenerationintheg93amouseananimalmodelofamyotrophiclateralsclerosis AT masahisakatsuno cablinhibitiondelaysmotorneurondegenerationintheg93amouseananimalmodelofamyotrophiclateralsclerosis AT kaorikawai cablinhibitiondelaysmotorneurondegenerationintheg93amouseananimalmodelofamyotrophiclateralsclerosis AT junsone cablinhibitiondelaysmotorneurondegenerationintheg93amouseananimalmodelofamyotrophiclateralsclerosis AT zhehuang cablinhibitiondelaysmotorneurondegenerationintheg93amouseananimalmodelofamyotrophiclateralsclerosis AT hiroakiadachi cablinhibitiondelaysmotorneurondegenerationintheg93amouseananimalmodelofamyotrophiclateralsclerosis AT fumiakitanaka cablinhibitiondelaysmotorneurondegenerationintheg93amouseananimalmodelofamyotrophiclateralsclerosis AT fumihikourano cablinhibitiondelaysmotorneurondegenerationintheg93amouseananimalmodelofamyotrophiclateralsclerosis AT gensobue cablinhibitiondelaysmotorneurondegenerationintheg93amouseananimalmodelofamyotrophiclateralsclerosis |
| _version_ |
1718422058657906688 |